FI971075L - (1,2,4)triatsolo(4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö - Google Patents

(1,2,4)triatsolo(4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö Download PDF

Info

Publication number
FI971075L
FI971075L FI971075A FI971075A FI971075L FI 971075 L FI971075 L FI 971075L FI 971075 A FI971075 A FI 971075A FI 971075 A FI971075 A FI 971075A FI 971075 L FI971075 L FI 971075L
Authority
FI
Finland
Prior art keywords
triazolo
preparation
quinoxalinone derivatives
quinoxalinone
derivatives
Prior art date
Application number
FI971075A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971075A7 (fi
FI971075A0 (fi
Inventor
Flemming Elmelund Nielsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI971075A0 publication Critical patent/FI971075A0/fi
Publication of FI971075A7 publication Critical patent/FI971075A7/fi
Publication of FI971075L publication Critical patent/FI971075L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI971075A 1994-09-16 1995-09-12 (1,2,4)triatsolo(4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö FI971075L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK106594 1994-09-16
PCT/DK1995/000364 WO1996008492A1 (en) 1994-09-16 1995-09-12 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE

Publications (3)

Publication Number Publication Date
FI971075A0 FI971075A0 (fi) 1997-03-14
FI971075A7 FI971075A7 (fi) 1997-05-13
FI971075L true FI971075L (fi) 1997-05-13

Family

ID=8100599

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971075A FI971075L (fi) 1994-09-16 1995-09-12 (1,2,4)triatsolo(4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö

Country Status (23)

Country Link
US (1) US6001832A (da)
EP (1) EP0783504B1 (da)
JP (1) JPH10505601A (da)
CN (1) CN1083842C (da)
AT (1) ATE190616T1 (da)
AU (1) AU706737B2 (da)
CA (1) CA2200055A1 (da)
CZ (1) CZ285248B6 (da)
DE (1) DE69515680T2 (da)
DK (1) DK0783504T3 (da)
ES (1) ES2146769T3 (da)
FI (1) FI971075L (da)
GR (1) GR3033642T3 (da)
HU (1) HUT76810A (da)
IL (1) IL115300A (da)
NO (1) NO308796B1 (da)
NZ (1) NZ292107A (da)
PL (1) PL319176A1 (da)
PT (1) PT783504E (da)
RU (1) RU2149162C1 (da)
SK (1) SK282635B6 (da)
WO (1) WO1996008492A1 (da)
ZA (1) ZA957795B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1285834A (zh) 1997-11-11 2001-02-28 小野药品工业株式会社 稠合吡嗪化合物
US8299080B2 (en) 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
MX2011009314A (es) 2009-03-05 2011-10-11 Astellas Pharma Inc Compuesto de quinoxalina.
KR20130097178A (ko) 2010-09-07 2013-09-02 아스텔라스세이야쿠 가부시키가이샤 퀴녹살린 화합물
NZ607527A (en) * 2010-09-16 2015-04-24 Hutchison Medipharma Ltd Fused heteroaryls and their uses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) * 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
DD228811A1 (de) * 1984-04-17 1985-10-23 Hydrierwerk Rodleben Veb Verfahren zur herstellung von neuen triazolopyrimidinen
GB8512163D0 (en) * 1985-05-14 1985-06-19 Fujisawa Pharmaceutical Co Oxothiazolidine compound
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
DK162491D0 (da) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
WO1993020077A1 (fr) * 1992-04-03 1993-10-14 Yamanouchi Pharmaceutical Co., Ltd. Derive de quinoxalinone fondue et composition pharmaceutique le contenant
DK31093D0 (da) * 1993-03-19 1993-03-19 Novo Nordisk As
NZ266127A (en) * 1993-05-06 1997-11-24 Novo Nordisk As Quinoxaline derivatives, preparation and medicaments

Also Published As

Publication number Publication date
JPH10505601A (ja) 1998-06-02
EP0783504A1 (en) 1997-07-16
FI971075A7 (fi) 1997-05-13
SK33597A3 (en) 1998-02-04
SK282635B6 (sk) 2002-10-08
HUT76810A (en) 1997-11-28
NO971186D0 (no) 1997-03-14
WO1996008492A1 (en) 1996-03-21
DE69515680D1 (de) 2000-04-20
EP0783504B1 (en) 2000-03-15
CZ285248B6 (cs) 1999-06-16
DE69515680T2 (de) 2000-10-19
IL115300A (en) 2001-06-14
FI971075A0 (fi) 1997-03-14
CN1083842C (zh) 2002-05-01
NO971186L (no) 1997-05-15
AU706737B2 (en) 1999-06-24
PT783504E (pt) 2000-08-31
CA2200055A1 (en) 1996-03-21
US6001832A (en) 1999-12-14
GR3033642T3 (en) 2000-10-31
DK0783504T3 (da) 2000-08-14
CZ75497A3 (en) 1997-08-13
AU3380795A (en) 1996-03-29
NO308796B1 (no) 2000-10-30
CN1193974A (zh) 1998-09-23
ZA957795B (en) 1996-05-14
ATE190616T1 (de) 2000-04-15
ES2146769T3 (es) 2000-08-16
NZ292107A (en) 1999-02-25
IL115300A0 (en) 1995-12-31
RU2149162C1 (ru) 2000-05-20
PL319176A1 (en) 1997-08-04

Similar Documents

Publication Publication Date Title
FI971225L (fi) Pyrrolo(2,3-d)pyrimidiinit ja niiden käyttö
FI955235A7 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
AU694699B2 (en) Pyrazolo-(1,5-a)-pyrimidine derivatives, their preparation and hair dyes containing these
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
FI952179A7 (fi) Uusia 3,3-difenyylipropyyliamiineja, niiden käyttö ja valmistus
FI20000516A7 (fi) Bis-indolyylimaleimidijohdannaiset ja niiden valmistus
AU1315797A (en) Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
NL300295I1 (nl) 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan
FI990134A0 (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
FI940696L (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
HUP9904032A3 (en) 1,2,4-benzothiadiazine derivatives,their preparation and use
FI954386L (fi) (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö
AU2464197A (en) Triazine derivatives and their use
DE69633503D1 (de) 1,2,4- triazolo (4,3-b) pyridazinderivate und ihre verwendung
FI955304L (fi) (1,2,4)triatsoli(4,3-a)kinoksaliiniyhdisteitä, niiden valmistus ja käyttö
EG21121A (en) 13 Substituted milbemycin derivatives their preparation and use
FI940186A7 (fi) 9H-imidatso/1,2-a/bentsimidatsoli-3-asetamidijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
FI923458A7 (fi) 4,5-sykloalkano-3-bentsatsepin-7-olijohdannaiset ja niiden käyttö
FI970750L (fi) Indoli-2,3-dioni-3-oksimijohdannaisia, niiden valmistus ja käyttö
FI971075L (fi) (1,2,4)triatsolo(4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö
FI971076A7 (fi) (1,2,4)triatsolo (4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use